US FDA Approves First-Line Use of Boehringer Ingelheim’s Lung Cancer Drug
The US Food and Drug Administration (FDA) has approved the first-line use of Boehringer Ingelheim’s lung cancer therapy zongertinib for […]
NSCLC
New Radiation Therapy for Lung Cancer Treatment
A new radiation therapy, which was in use to treat prostate, brain, and head and neck cancers, can reduce chemotherapy […]
